CONy 2020 | Using biomarkers to identify true ischemia

Andrew Demchuk, MD, FRCPC, Hotchkiss Brain Institute, University of Calgary, Calgary, Canada, discusses the potential of biomarkers to identify patients with true ischemia. In practice, MRI is a limited resource and is not always available immediately. Therefore, the use of a less expensive method, like biomarkers, would be beneficial. This interview took place during the Virtual World Congress on Controversies in Neurology (CONy) 2020.